Skip to content

A study of the use of safety plans to reduce self-harm and suicide for autistic adults

Adapted suicide safety plans to address self harm, suicidal ideation and suicide behaviours in autistic adults: an interventional single arm feasibility trial and external pilot randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70594445
Enrollment
155
Registered
2020-07-06
Start date
2020-09-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intentional self-harm, autism spectrum disorder Mental and Behavioural Disorders Intentional self-harm, autism spectrum disorder, ASD

Interventions

The intervention will be Autism Suicide Safety Plans (SPs), adapted in partnership with autistic people and those who support them, compared to usual care. SPs consist of a prioritized list of hierarc

Sponsors

Newcastle University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults with a clinical diagnosis of ASD 2. Accessing services via charities or third sector autism or third sector mental health services 3. A self-reported history of self-harm, suicidal thoughts or behaviours within the last 6 months 4. Sufficient spoken English to take part in assessments 5. Aged =18 years

Exclusion criteria

Exclusion criteria: 1. Insufficient English language skills or literacy to complete the SP and outcome measures (in a future definitive trial we will aim to develop versions of the materials in a range of languages) 2. Current psychotic symptoms

Design outcomes

Primary

MeasureTime frame
Self-harm without intent to die will be assessed using a semi-structured interview; the Self Injurious Thoughts and Behaviours Interview (SITBI), at baseline, 1 and 6 months

Secondary

MeasureTime frame
1. Psychiatric status of participants, including suicidality, will be assessed with a semi-structured interview; the Mini International NeuroPsychiatric Interview at baseline, 1 and 6 months 2. Assessment of the presence of adverse/difficult life experiences will be assessed by questionnaire completion using the Vulnerability Experience Quotient at baseline, 1 and 6 months 3. Demographic characteristics including socio-economic status, employment, housing, access to support, physical health, education, major life events will be captured using a questionnaire at baseline and 6 months 4. Health-related quality of life in relation to mobility, self-care, usual activities, pain/discomfort and anxiety/depression measured using the EQ-5D-5L at baseline and 6 months 5. Health state utilities for use as part of a cost-benefit or cost-utility analysis will be assessed using a Health Economics Preference Elicitation tool developed for the study at baseline and 6 months 6. Information relating to participants' use of NHS, local authority and third sector services over the previous 6 months, captured using a Treatment as Usual/Usual Care Questionnaire designed specifically for the study at baseline and 6 months 7. An economic benefit assessment of the safety plan intervention will be assessed using an economic benefit assessment questionnaire at 6 months 8. How usable autistic adults find the safety plans will be captured using the questionnaire System Usability Scale (SUS) at 6 months 9. Participant satisfaction with the safety plans will be recorded using the Client Satisfaction Questionnaire-8 (CSQ-8) at 6 months 10. Interviews with the autistic adults who have participated to gain feedback on their views of the research methods, outcome measures and the safety plans, at 6 months 11. Interviews with support staff who have participated in the study to gain feedback on the views of the research methods, outcome measures, and the safety plans, at 6 months 12. The followin

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 12, 2026